SurgiQuest has developed a radically different laproscopic trocar design that eliminates the circular seals and duckbill valves that had plagued conventional trocars since the early 1990’s. SurgiQuest developed a valve-free trocar and circulatory insufflation unit that became the foundation of AirSealĀ®, the world’s first and only integrated access system for laproscopic and robotic surgery.

SurgiQuest was acquired by Conmed Corporation (NASDAQ: CNMD)